U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07200570) titled 'Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy' on Sept. 23.
Brief Summary: The goal of this clinical trial is to learn if a chatbot powered by artificial intelligence works to improve HPV vaccination among females aged 15 to 26 in China. A randomized controlled trial and implementation science study will be conducted targeting females as participants. The main questions it aims to answer are:
1. Does the vaccine chatbot influence women's confidence, literacy, hesitancy, and uptake of the HPV vaccine.
2. What are the public acceptance of chatbot and the facilitators and barriers to its implementation in a r...